Skip to main content
. Author manuscript; available in PMC: 2019 Jul 12.
Published in final edited form as: Gynecol Oncol. 2018 Jul;150(1):44–49. doi: 10.1016/j.ygyno.2018.04.571

Table 5.

Factors associated with disease-specific survival

Variable Univariate Multivariable

HR (95% CI) p value Adjusted HR (95% CI) p value
Median age 0.98 (0.95 – 1.01) .162
Race
 White Referent -- -- --
 Black 1.52 (0.90 – 2.59) .121
 Hispanic 1.23 (0.84 – 1.81) .279
 Other 1.35 (0.77 – 2.36) .295
Histology
 Squamous cell Referent -- Referent --
 Adenocarcinoma 0.70 (0.45 – 1.11) .132 1.02 (0.63 – 1.64) .940
 Adenosquamous 2.41 (1.58 – 3.67) <.001 2.37 (1.55 – 3.63) <.001
Grade
 G1 Referent -- Referent --
 G2 2.64 (1.06 – 6.61) .038 1.96 (0.76 – 5.08) .164
 G3 4.65 (1.88 – 11.48) .001 2.86 (1.11 – 7.51) .030
 Unknown 1.60 (0.51 – 5.05) .420 1.45 (0.45 – 4.70) .532
Tumor size
 ≤ 2 cm Referent -- Referent --
 > 2 cm 2.56 (1.82 – 3.62) <.001 1.82 (1.26 – 2.62) .001
 Unknown NE .962 NE .963
Surgery
 Less radical Referent -- Referent --
 More radical 1.13 (0.78 – 1.63) .511 0.99 (0.69 – 1.44) .969
Positive LN
 No Referent -- Referent --
 Yes 3.03 (2.16 – 4.24) <.001 2.42 (1.70 – 3.42) <.001
 Unknown if examined NE .959 NE .988
*RT
 No Referent -- -- --
 Yes 3.07 (2.21 – 4.26) <.001
*RT type
 None Referent -- -- --
 External beam 3.10 (2.17 – 4.43) <.001
 Brachytherapy 5.50 (2.00 – 15.09) .001
 Both 2.63 (1.55 – 4.49) <.001
 RT NOS 5.35 (0.74 – 38.59) .096

Abbreviations: LN, lymph node; RT, radiation therapy; NOS, not otherwise specified; NE = Not estimable

*

Not included in multivariable analysis due to multicollinearity